This brings the total number of confirmed human cases in Massachusetts to eight this season, and the risk level for the virus ...
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced results from new analyses of the HELIOS-B Phase 3 study of AMVUTTRA® (vutrisiran), an RNAi ...
At Month 42, continuous acoramidis was associated with lower risk of all-cause mortality (ACM), first CVH, and ACM/first CVH vs placebo to acoramidis switch in both wild-type ATTR-CM and variant ...
Now that October is upon us, it is time to start thinking about the upcoming flu season and how to protect yourself and ...
When Is the Best Time to Take Metformin? This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. We get it — no one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results